Crystallochemistry, textural properties, and in vitro biocompatibility of different silicon-doped calcium phosphates

Journal of Biomedical Materials Research - Part A

Volumn 78, Issue 4, 2006, Pages 762-771

  Arcos, D ^a,b   Sanchez Salcedo S ^a   Izquierdo Barba, I ^a   Ruiz, L ^c   Gonzalez Calbet J ^c   Vallet Regi M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b DEPARTMENT OF PHYSICAL METALLURGY   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Biocompatibility; Calcium phosphate; Cell cultures; Silicon

Indexed keywords

BIOCOMPATIBILITY; CELL CULTURE; CELLS; DOPING (ADDITIVES); GLASS; HEAT TREATMENT; SILICON; SYNTHESIS (CHEMICAL); TOXICITY;

BIOCERAMICS; CALCIUM PHOSPHATES; CRYSTALLOCHEMISTRY; CYTOTOXICITY;

CALCIUM COMPOUNDS;

APATITE; CALCIUM PHOSPHATE; GLASS; NANOCRYSTAL; SILICON;

ARTICLE; BIOCOMPATIBILITY; CELL DAMAGE; CELL PROLIFERATION; CERAMICS; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; HEAT TREATMENT; HEATING; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOBLAST; PRECIPITATION; SYNTHESIS; X RAY DIFFRACTION;

BIOCOMPATIBLE MATERIALS; CALCIUM PHOSPHATES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CRYSTALLIZATION; CULTURE MEDIA; HUMANS; L-LACTATE DEHYDROGENASE; MICROSCOPY, ELECTRON, SCANNING; SILICON; X-RAY DIFFRACTION;

EID: 33748069769     PISSN: 00219304     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30790     Document Type: Article

References (36)

1. Hench LL, Polak JM. Third generation biomedical materials. Science 2002;295:1014-1017.
2. Vallet-Regí M. Ceramics for medical applications, J Chem Soc Dalton 2001;2:97-108.
3. Kokubo T. Bioactive glass-ceramics: Properties and applications. Biomaterials 1991;12:155-163.
4. Hench LL. Bioceramics: From concept to clinic. J Am Ceram Soc 1991;74:1487-1570.
5. Jones JR, Hench LL. Biomedical materials for new millennium: Perspective on the future. Mater Sci Tech 2001;17:891-900.
6. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-926.
7. Nerem RM, Sambanis A. Tissue egineering: From biology to biological substitutes. Tissue Eng 1995;1:3-13.
8. Vallet-Regí M, Arcos D. Silicon substituted hydroxyapatites. A method to upgrade calcium phosphate based implants. J Mater Chem 2005;15;1509-1516.
9. Gibson IR, Huang J, Best SM, Bonfield W. Enhanced in vitro cell activity and surface apatite layer formation on novel silicon-substituted hydroxyapatites. In: Ohgushi H, Hastings GW, Yoshikawa T, editors. Bioceramics 12. Singapore: World Scientific; 1999. p 191-194.
10. Hing KA, Saeed S, Annaz B, Buckland T, Reveil PA. Bone development is sensitive to silicon level in substituted apatites. In: Transactions 7th World Biomaterials Congress. Sidney: 2004. p 108.
11. Porter AE, Patel N, Skepper JN, Best SM, Bonfield W. Effect of sintered silicate-substituted hydroxyapatite on remodelling processes at the bone-implant interface. Biomaterials 2004;25:3303-3314.
12. Ruys AJ. Silicon-doped hydroxyapatite. J Aust Ceram Soc 1993; 29:71-80.
13. Tanizawa Y, Suzuki T. Effects of silicate ions on the formation and transformation of calcium phosphates in neutral aqueoussolutions. J Chem Soc Faraday Trans 1995;91:3499-3500.
14. Arcos D, Rodríguez-Carvajal J, Vallet-Regi M. The effect of the silicon incorporation on the hydroxyapatite structure. A neutron diffraction study. Solid State Sci 2004;6:987-994.
15. Gibson IR, Best SM, Bonfield W. Chemical characterisation of silicon-substituted hydroxyapatite. J Biomed Mater Res 1999; 44:422-428.
16. Best SM, Bonfield W, Gibson IR, Jha LJ, Santos JD. International Patent Appl No. PCT/GB97/02325 1996.
17. Gibson IR, Best SM, Bonfield W. Effect of silicon substitution on the sintering and microstructure of hydroxyapatite. J Am Ceram Soc 2002;85:2771-2777.
18. Kim SR, Lee JH, Kim YT, Riu DH, Jung SJ, Lee YJ, Chung SC, Kim YH. Synthesis of Si, Mg substituted hydroxyapatite and their sintering behaviors. Biomaterials 2003;24:1389-1398.
19. Marques PA, Magalhaes MCF, Correia RN, Vallet-Regi M. Synthesis and characterisation of silicon-substituted hydroxyapatite. Key Eng Mater 2001;247:192-195.
20. Kim SR, Riu DH, Lee YJ, Kim YH. Synthesis and characterization of silicon substituted hydroxyapatite. Key Eng Mater 2002; 85:218-220.
21. Arcos D, Rodríguez-Carvajal J, Vallet-Regí M. Silicon incorporation in hydroxyapatite obtained by controlled crystallization. Chem Mater 2004;16:2300-2308.
22. Langstaff S, Sayer M, Smith TJN, Pugh SM. Resorbable bioceramics based on stabilized calcium phosphates. Part II: evaluation of biological response. Biomaterials 2001;22:135-150.
23. Chavassieux PM, Chenu C, Valentin-Opran A, Merle B, Delmas PD, Hartmann DJ, Saez S, Meunier PJ. Influence of experimental conditions on osteoblast activity in human primary bone cell cultures. J Bone Miner Res 1990;5:337-343.
24. Rodríguez-Carvajal J. Recent advances in magnetic structure determination by neutron powder diffraction. Physica B 1993; 192:55-69.
25. Kay MI, Young RA, Posner AS. Crystal structure of hydroxyapatite. Nature 1964;204:1050-1052.
26. Reddi AH, Huggins CB. Citrate and alkaline phosphatase during transformation of fibroblast by the matrix and minerals of bone. Proc Soc Exp Biol Med 1972;140:807-810.
27. Sayer M, Stratilatov AD, Reid J, Calderin L, Stott MJ, Yin X, MacKenzie M, Smith TJN, Hendry JA, Langstaff SD. Structure and composition of silicon-stabilized tricalcium phosphate. Biomaterials 2003;24:369-382.
28. Balzar D. Defect and microstructure analysis by diffraction. In: Snyder RL, Bunge HJ, Fiala J, editors. Oxford: University Press; 1999. p 94-126.
29. Brinker CJ, Scherer GW. Sol-Gel Science: The Physics and Chemistry of Sol-Gel Procesing. San Diego: Academic Press; 1990. p 522-525.
30. Frayssisnet P, Rouquet N, Fages J, Durand M, Vidalain PO, Bonel G. The influence of sintering temperature on the proliferation of fibroblastic cells in contact with HA-bioceramics. J Biomed Mater Res 1997;35:337-347.
31. Radin SR, Ducheyne P. The effect of calcium phosphate ceramic composition and structure on in vitro behaviour. II. Precipitation. J Biomed Mater Res 1993;27:35-45.
32. Yin X, Stott MJ. Theoretical insights into bone grafting silicon-stabilized α-tricalcium phosphate. J Chem Phys 2005; 122:024709-024718.
33. Alliot-Licht B, Gregoire M, Orly I, Menanteau J. Cellular activity of osteoblasts in the presence of hydroxyapatite: An in vitro experiment. Biomaterials 1991;12:752-756.
34. Orly I, Grégoire M, Menanteau J, Dard M. Effects of synthetic calcium phosphates on the 3H-thymidine incorporation and alkaline phosphatase activity of human fibroblasts in culture. J Biomed Mater Res 1989;23:1433-1440.
35. Ong JL, Hoppe CA, Cardenas HL, Cavin R, Carnes DL, Sogal A, Raikar GN. Osteoblast precursor cell activity on HA surfaces of different treatments. J Biomed Mater Res 1998;39:176-183.
36. Xynos ID, Hukkanen MVJ, Batten JJ, Buttery LD, Hench LL, Polak JM. Bioglass ®45S5 Stimulates osteoblast turnover and enhances bone formation in vitro: Implications and applications for bone tissue engineering. Calcif Tissue Int 2000;67:321-329.